全文获取类型
收费全文 | 1485篇 |
免费 | 102篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 54篇 |
妇产科学 | 24篇 |
基础医学 | 223篇 |
口腔科学 | 70篇 |
临床医学 | 127篇 |
内科学 | 403篇 |
皮肤病学 | 6篇 |
神经病学 | 106篇 |
特种医学 | 32篇 |
外科学 | 198篇 |
综合类 | 9篇 |
预防医学 | 65篇 |
眼科学 | 14篇 |
药学 | 103篇 |
中国医学 | 12篇 |
肿瘤学 | 129篇 |
出版年
2022年 | 7篇 |
2021年 | 21篇 |
2020年 | 18篇 |
2019年 | 36篇 |
2018年 | 55篇 |
2017年 | 24篇 |
2016年 | 28篇 |
2015年 | 33篇 |
2014年 | 43篇 |
2013年 | 64篇 |
2012年 | 91篇 |
2011年 | 104篇 |
2010年 | 52篇 |
2009年 | 50篇 |
2008年 | 64篇 |
2007年 | 82篇 |
2006年 | 90篇 |
2005年 | 87篇 |
2004年 | 55篇 |
2003年 | 53篇 |
2002年 | 45篇 |
2001年 | 32篇 |
2000年 | 24篇 |
1999年 | 15篇 |
1998年 | 11篇 |
1997年 | 5篇 |
1995年 | 14篇 |
1993年 | 5篇 |
1992年 | 21篇 |
1991年 | 20篇 |
1990年 | 22篇 |
1989年 | 27篇 |
1988年 | 19篇 |
1987年 | 29篇 |
1986年 | 39篇 |
1985年 | 15篇 |
1984年 | 18篇 |
1983年 | 18篇 |
1982年 | 14篇 |
1980年 | 9篇 |
1979年 | 15篇 |
1978年 | 12篇 |
1977年 | 8篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1974年 | 10篇 |
1973年 | 15篇 |
1972年 | 12篇 |
1971年 | 6篇 |
1967年 | 6篇 |
排序方式: 共有1587条查询结果,搜索用时 31 毫秒
21.
Ma Yuan Sajeev Gautam VanderWeele Tyler J. Viswanathan Anand Sigurdsson Sigurdur Eiriksdottir Gudny Aspelund Thor Betensky Rebecca A. Grodstein Francine Hofman Albert Gudnason Vilmundur Launer Lenore Blacker Deborah 《European journal of epidemiology》2022,37(6):591-601
European Journal of Epidemiology - The apolipoprotein E allele 4 (APOE-ε4) is established as a major genetic risk factor for cognitive decline and late-onset Alzheimer’s disease.... 相似文献
22.
Ragnhammar P Frodin J Hjelm A Fagerberg J Wersall P Lindemalm C Nilsson B Fox K Magnusson I Ewerth S Thor K Secher E Mellstedt H 《International journal of oncology》1995,7(5):1049-1056
Seventy-one patients with metastatic colorectal carcinoma(CRC) were treated with varying doses of the mouse monoclonal antibody (MAb) 17-1A. One patient achieved a partial remission (PR) (1%) with a survival duration of 114+ months. Further 10 patients showed a minor response (MR) or stable disease > 3 months (SD) (14%). In patients receiving a total dose of MAb17-1A < 2 g the overall response rate was 22% (10/45) (1 PR, 2 MR, 7 SD) while patients treated with a total dose > 2 g had a corresponding figure of 4% (1/26) (1 MR) (p < 0.05). Responding patients (n = 11) survived significantly longer than non-responding patients (n = 60) (median: 20 vs 10 months) (p < 0.0027). In the most intensive treatment group (total 12 g), 14 patients received 500 mg of MAb17-1A tiw for 8 weeks. The frequency and intensity of side-effects were mild and did not cause withdrawal or dose reduction of MAb17-1A, even in the 12 g dose schedule. Patients with a pretreatment ADCC (antibody dependent cellular cytotoxicity) activity above the median of all patients, survived significantly longer than those with a low value (p < 0.05). 相似文献
23.
Jonsdottir IH Sjöqvist A Lundgren O Thorén P 《Journal of the autonomic nervous system》1999,78(1):18-23
The effects of somatic nerve stimulation on cholera toxin induced secretion was investigated in vivo in anaesthetised rats. Small intestinal secretion was induced with cholera toxin and measured by a gravimetric technique. Afferent stimulation (pulse frequency within train; 100 Hz; train duration: 50 ms; train frequency: 3 Hz) of the sciatic nerve over 30 min significantly reduced the net fluid secretion both during (P < 0.05) and after cessation of the stimulation (P < 0.01). The greatest effect was obtained immediately after the termination of the nerve stimulation when the secretion was reversed to net fluid absorption. The opioid receptor antagonist naloxone (10 mg kg(-1) i.v.) administrated during the stimulation, significantly inhibited the antisecretory effect seen after the stimulation, thus no significant difference was seen between the control period and the periods after cessation of the stimulation. The opioid receptor antagonist naloxone methiodide (10 mg kg(-1) i.v.), which does not cross the blood-brain barrier, partly inhibited the antisecretory effects but not with the same magnitude as naloxone, thus the net fluid secretion was still significantly inhibited after the stimulation (P < 0.05). We conclude that afferent stimulation of the sciatic nerve strongly inhibits the cholera toxin induced secretion in the small intestine. This inhibition involves primarily a central opioid mechanism and to a lesser extent peripheral opioid mechanism. 相似文献
24.
Physical activities such as long-distance running can be habit forming and associated with a sense of well-being to a degree that justifies comparison with drug-induced addictive behaviours. To understand molecular similarities and dissimilarities controlling these behaviours in humans we compared the effects of running in running wheels to the effects of chronic cocaine or morphine administration on mRNA levels in brain reward pathways in the inbred Fischer and Lewis rat strains. These strains are both inbred from the Sprague-Dawley strain; Lewis rats display a higher preference towards addictive drugs and running than do Fischer rats. After chronic cocaine or running a similar increase of dynorphin mRNA in medial caudate putamen was found in the Lewis rat, suggesting common neuronal adaptations in this brain region to both cocaine and running. Fischer and Lewis rats both responded to cocaine with increased dynorphin mRNA levels in medial caudate putamen. However, only Lewis rats increased dynorphin mRNA after running, possibly reflecting the much higher degree of running by the Lewis strain as compared to the Fischer strain. Moreover, the running-induced upregulation of dynorphin mRNA was blocked by the opioid receptor antagonist naloxone. We suggest that running increases dynorphin mRNA by a mechanism that involves endogenous opioids. The voluntary wheel-running model in rats might be used to study natural reward and compulsive behaviours and possibly also to screen candidate drugs for treatment of compulsive disorders. 相似文献
25.
Anne Marie Asemissen Carmen Scheibenbogen Anne Letsch Kristoffer Hellstrand Fredrik Thorén Kurt Gehlsen Alexander Schmittel Eckhard Thiel Ulrich Keilholz 《Clinical cancer research》2005,11(1):290-297
PURPOSE: Preclinical investigations suggest that histamine dihydrochloride (HDC) protects T cells and natural killer cells from inhibition by monocyte-derived reactive oxygen metabolites and synergizes with interleukin (IL) 2 in inducing T-cell activation. Here, we investigate whether this mechanism is operational in patients with melanoma treated with HDC as an adjunct to IL-2. EXPERIMENTAL DESIGN: Melanoma patients having liver metastases were treated with IL-2 with or without HDC within a randomized, multicenter, phase III trial. The effect of HDC on type 1 and type 2 T-cell cytokine production was investigated in peripheral blood samples from 19 patients with the use of intracellular cytokine flow cytometry. Melanoma-specific T-cell responses were analyzed in eight HLA-A2-positive patients. RESULTS: Frequencies of CD3+ T cells producing IFN-gamma (type 1 T cells) in response to phorbol myristate acetate/ionomycin increased (median, 1.8-fold) in patients receiving IL-2 plus HDC but not in those receiving IL-2 alone (P < 0.01 for comparison between arms). In contrast, the number of IL-13-producing type 2 T cells that increased in patients after treatment with IL-2 was not modulated by HDC. Melanoma- and tyrosinase-specific IFN-gamma and IL-13-producing T cells were detected in two of four HLA-A2-positive patients with melanoma following treatment with HDC + IL-2. CONCLUSIONS: Treatment of patients with stage IV melanoma with HDC in combination with IL-2 increases type 1 T-cell responses and may promote induction of melanoma-specific T cells. These effects are of relevance for tumor immunotherapy and provide a potential mechanism for the clinical efficacy of HDC added to IL-2. 相似文献
26.
27.
With increasing rates of obesity and new diagnostic criteria for gestational diabetes mellitus (GDM), the overall prevalence of GDM is increasing worldwide. Women with GDM have an increased risk of maternal and fetal complications during pregnancy as well as long-term risks including higher prevalence of type 2 diabetes mellitus and cardiovascular disease. In recent years, the role of immune activation and inflammation in the pathogenesis of GDM has gained increasing attention. This monograph explores the current state of the literature as regards the expression of markers of inflammation in the maternal circulation, placenta, and adipose tissue of women with GDM. 相似文献
28.
29.
Amir Dasmah Andreas Thor Annika Ekestubbe Lars Sennerby Lars Rasmusson 《Journal of cranio-maxillo-facial surgery》2012,40(8):654-659
BackgroundExtensive alveolar bone resorption in the maxilla limits the possibility of successful placement and osseointegration of endosseous implants for future prosthetic rehabilitation. Autogenous bone from the iliac crest may be used as lateral onlays in the atrophic maxilla, both as block and particulate bone. To our knowledge, there is no three-dimensional 2-year follow-up study measuring the volumetric reduction of the augmented areas comparing particulate and block bone grafts.PurposeThe aim of this study was to conduct a radiographic 2-year follow-up study, using computed tomographic (CT) images in order to evaluate and compare the extent of bone graft resorption in the frontal maxillae augmented by particulate (test) and block bone (control).Material and methodsEleven patients treated with iliac bone grafts and oral implants in the maxilla were followed with CT examinations directly post grafting and after 2 years.ResultThe volumetric changes after 6 months were extensive. Additionally, the changes in particulate bone tended to be larger after 2 years compared to block bone, using this protocol. However, the difference was not statistically significant.ConclusionThe present follow-up study showed that there is radiographically complete integration and embedding of implants installed in grafted bone despite extensive initial graft resorption. There was no significant difference in the amount of volumetric reduction between particulate bone and block bone grafts. 相似文献
30.
Ann C. McKee Nigel J. Cairns Dennis W. Dickson Rebecca D. Folkerth C. Dirk Keene Irene Litvan Daniel P. Perl Thor D. Stein Jean-Paul Vonsattel William Stewart Yorghos Tripodis John F. Crary Kevin F. Bieniek Kristen Dams-O’Connor Victor E. Alvarez Wayne A. Gordon the TBI/CTE group 《Acta neuropathologica》2016,131(1):75-86